Completion pancreatectomy for recurrent pancreatic cancer in the remnant pancreas: report of six cases and a review of the literature.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 26545606)

Published in Langenbecks Arch Surg on November 06, 2015

Authors

Yasuo Shima1, Takehiro Okabayashi2, Akihito Kozuki2, Tatsuaki Sumiyoshi2, Teppei Tokumaru2, Yuichi Saisaka2, Keiichi Date2, Jun Iwata3

Author Affiliations

1: Department of Gastroenterological Surgery, Kochi Health Sciences Center, 2125-1 Ike, Kochi, 781-8555, Japan. yasuo_shima@khsc.or.jp.
2: Department of Gastroenterological Surgery, Kochi Health Sciences Center, 2125-1 Ike, Kochi, 781-8555, Japan.
3: Department of Diagnostic Pathology, Kochi Health Sciences Center, Kochi, Japan.

Articles cited by this

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med (1993) 102.56

Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA (2007) 14.54

A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med (2004) 13.34

1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience. J Gastrointest Surg (2006) 7.18

Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma. Ann Surg Oncol (2009) 3.22

Recurrence after resection for ductal adenocarcinoma of the pancreas. World J Surg (1997) 2.56

Long-term survival and metastatic pattern of pancreatic and periampullary cancer after adjuvant chemoradiation or observation: long-term results of EORTC trial 40891. Ann Surg (2007) 2.48

Surgery for recurrent pancreatic ductal adenocarcinoma. Ann Surg (2007) 1.85

A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer. Br J Cancer (2009) 1.84

Management of patients with pancreatic adenocarcinoma: national trends in patient selection, operative management, and use of adjuvant therapy. J Am Coll Surg (2011) 1.64

Is there still a role for total pancreatectomy? Ann Surg (2007) 1.52

Combined chemoradiotherapy for isolated local recurrence after primary resection of pancreatic cancer. JOP (2006) 1.27

Re-resection for isolated local recurrence of pancreatic cancer is feasible, safe, and associated with encouraging survival. Ann Surg Oncol (2012) 1.21

Repeated pancreatectomy after pancreatoduodenectomy. J Gastrointest Surg (2007) 1.14

Remnant pancreatectomy for recurrent or metachronous pancreatic carcinoma detected by FDG-PET: two case reports. JOP (2010) 1.08

Chemoradiation in patients with isolated recurrent pancreatic cancer - therapeutical efficacy and probability of re-resection. Radiat Oncol (2013) 1.03

Repeat pancreatectomy for pancreatic ductal cancer recurrence in the remnant pancreas after initial pancreatectomy: is it worthwhile? Surgery (2013) 1.02

Selective reoperation for locally recurrent or metastatic pancreatic ductal adenocarcinoma following primary pancreatic resection. J Gastrointest Surg (2012) 1.01

Reoperative completion pancreatectomy for suspected malignant disease of the pancreas. J Surg Res (2011) 0.98

Total pancreatectomy: indications, different timing, and perioperative and long-term outcomes. Surgery (2010) 0.98

Radiotherapy for patients with isolated local recurrence of primary resected pancreatic cancer. Prolonged disease-free interval associated with favorable prognosis. Strahlenther Onkol (2014) 0.89

S-1 vs. gemcitabine as an adjuvant therapy after surgical resection for ductal adenocarcinoma of the pancreas. World J Surg (2014) 0.83